Euclidean Technologies Management’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,990
Closed -$1.52M 84
2021
Q4
$1.52M Sell
26,990
-2,000
-7% -$110K 1.27% 45
2021
Q3
$1.45M Hold
28,990
1.26% 47
2021
Q2
$1.65M Sell
28,990
-10,000
-26% -$588K 1.32% 44
2021
Q1
$2.04M Hold
38,990
1.78% 33
2020
Q4
$1.75M Hold
38,990
1.84% 34
2020
Q3
$1.41M Hold
38,990
1.77% 32
2020
Q2
$1.45M Hold
38,990
2.03% 21
2020
Q1
$1.02M Buy
+38,990
New +$1.48M 1.68% 35

Other funds holding CBT

Euclidean Technologies Management's CBT Position: Q1 2022 in Review

Euclidean Technologies Management sold out of Cabot Corp (CBT) in Q1 2022, closing a stake of 26,990 shares — an estimated $1.52M sold.

Euclidean Technologies Management first reported a position in CBT in Q1 2020 and held it in 8 quarters. The position peaked at $2.04M in Q1 2021. 289 funds tracked by Wall St. Rank hold CBT as of Q1 2022.

  • Euclidean Technologies Management reported no remaining Cabot Corp position as of Q1 2022 after selling out during the quarter.
  • Euclidean Technologies Management sold 26,990 Cabot Corp shares in Q1 2022, an estimated $1.52M.
  • Euclidean Technologies Management first reported a position in Cabot Corp in Q1 2020 and held it in 8 quarters.
  • Euclidean Technologies Management's Cabot Corp position peaked at $2.04M in Q1 2021.
  • 289 funds tracked by Wall St. Rank held Cabot Corp as of Q1 2022.

Based on Euclidean Technologies Management's 13F filing for Q1 2022, filed 28 Apr 2022.